It has now been over a decade since the human genome was first sequenced, but the utility of genomic findings in daily clinical medicine has grown at a snail’s pace. Recent advances in sequencing and genetic testing have lowered the cost of obtaining data on an individual patient, but research lags to provide solid guidance to clinicians, and patients, that will aid in diagnosis and treatment. Several recent pieces in the Journal of the American Medical Association focus on the role of genomics in medicine. In one, the authors discuss the need for better information systems to store and provide genomic information at the point of care. Current EHRs are not capable of storing the volume of information generated by genomic testing. And a useful information system would provide clinical decision support around genetic data, since most physicians do not feel they have adequate training in the field. (JAMA Article) Several articles in the current issue discuss other aspects of genomics in medical care and the research reports all deal with use of specific genetic findings in the diagnosis and treatment of disease. (JAMA Issue) The authors of several commentaries in this issue note the potential barriers to more widespread use of genomics, including cost, training of health professionals, privacy concerns and the usability of the data. Personalized medicine, which uses knowledge about the individual patient’s biochemistry, including not just raw genomic sequence, but also expression information, is a very appealing idea. But it requires that we have a very clear understanding of the linkage between the variations in that individual information and the clinical meaning of the variations. In a few areas, such as pharmacogenomics and cancer treatment, there is a good start, but for many widespread, chronic diseases, there is a need for much more research.
✅ Subscribe via Email
About this Blog
Healthy Skeptic Podcast
Research
MedPAC 2019 Report to Congress
June 18, 2019
Headlines
Tags
Access
ACO
Care Management
Chronic Disease
Comparative Effectiveness
Consumer Directed Health
Consumers
Devices
Disease Management
Drugs
EHRs
Elder Care
End-of-Life Care
FDA
Financings
Genomics
Government
Health Care Costs
Health Care Quality
Health Care Reform
Health Insurance
Health Insurance Exchange
HIT
HomeCare
Hospital
Hospital Readmissions
Legislation
M&A
Malpractice
Meaningful Use
Medicaid
Medical Care
Medicare
Medicare Advantage
Mobile
Pay For Performance
Pharmaceutical
Physicians
Providers
Regulation
Repealing Reform
Telehealth
Telemedicine
Wellness and Prevention
Workplace
Related Posts
Commentary
December 6, 2023
The Labor Market Begins to Implode
The latest labor data shows a declining labor market, with more bad news likely on…
Commentary
December 5, 2023
The Most Brilliant and Simple Defense of Freedom You Will See
Please cry for us Argentina, we have no one as brilliant as your new President.
Commentary
December 5, 2023
More Random Economic News
No matter what things look like on the surface, the economy and our nation's finances…